|
López-Jornet P, Pons-Fuster E, Ruiz-Roca JA. YOUTUBE videos on oral care of the organ or hematopoietic stem cell transplant patients. Support Care Cancer. 2017 Apr;25(4):1097-1101. doi: 10.1007/s00520-016-3497-3. Epub 2016 Nov 22. PubMed PMID: 27878369.
AÑO: 2017; IF: 2.676
|
27878369
|
Pons-Fuster López E, Wang QT, Wei W, López Jornet P. Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line. Arch Oral Biol. 2017 Oct;82:141-146. doi: 10.1016/j.archoralbio.2017.05.023. Epub 2017 Jun 19. PubMed PMID: 28641180.
AÑO: 2017; IF: 2.05
|
|
Pons-Fuster López E, Seoane Leston J, López Jornet P. Epigallocatechin-3-gallate reduces damage to osteoblast-like cells treated with Zoledronic acid. Arch Oral Biol. 2018 Oct;94:27-32. doi: 10.1016/j.archoralbio.2018.06.018. Epub 2018 Jun 20. PubMed PMID: 29945092.
AÑO: 2018; IF: 1.663
|
|
Ruiz-Roca JA, Pons-Fuster E, Lopez-Jornet P. Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson's Disease: A Systematic Review. J Clin Med. 2019 Mar 6;8(3):317. doi: 10.3390/jcm8030317. PubMed PMID: 30845700; PubMed Central PMCID: PMC6463012.
AÑO: 2019; IF: 3.303
|
|
Pons-Fuster Lopez E, Gomez Garcia F, Lopez Jornet P. Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation. Arch Oral Biol. 2019 May;101:8-12. doi: 10.1016/j.archoralbio.2019.02.018. Epub 2019 Feb 28. PubMed PMID: 30851692.
AÑO: 2019; IF: 1.931
|